Raxar
Brand names,
Raxar
Analogs
Raxar
Brand Names Mixture
Raxar
Chemical_Formula
C19H22FN3O3
Raxar
RX_link
http://www.rxlist.com/cgi/generic2/grepa.htm
Raxar
fda sheet
Raxar
msds (material safety sheet)
Raxar
Synthesis Reference
No information avaliable
Raxar
Molecular Weight
359.395 g/mol
Raxar
Melting Point
No information avaliable
Raxar
H2O Solubility
No information avaliable
Raxar
State
Solid
Raxar
LogP
2.119
Raxar
Dosage Forms
Tablet
Raxar
Indication
For treatment of adults with mild to moderate infections caused by susceptible strains of Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catarrhalis.
Raxar
Pharmacology
No information avaliable
Raxar
Absorption
Rapidly and extensively absorbed following oral administration. The absolute bioavailability is approximately 70%.
Raxar
side effects and Toxicity
Withdrawn from the US market in 1999 due to associations with QTc prolongation and adverse cardiovascular events.
Raxar
Patient Information
No information avaliable
Raxar
Organisms Affected
Enteric bacteria and other eubacteria